IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,580 | -54.3% | 1,226,400 | -29.2% | 0.01% | -44.4% |
| Q2 2023 | $12,198 | +6.4% | 1,732,700 | -7.6% | 0.02% | +20.0% |
| Q1 2023 | $11,459 | -44.0% | 1,875,500 | -41.4% | 0.02% | -46.4% |
| Q4 2022 | $20,454 | -99.7% | 3,200,900 | +295.9% | 0.03% | +154.5% |
| Q3 2022 | $7,746,000 | +50.3% | 808,600 | +199.5% | 0.01% | +83.3% |
| Q4 2021 | $5,154,000 | +15.8% | 270,000 | +92.0% | 0.01% | 0.0% |
| Q1 2021 | $4,451,000 | +298.5% | 140,600 | +129.0% | 0.01% | +500.0% |
| Q3 2019 | $1,117,000 | – | 61,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 19,997,103 | $90,986,819 | 11.15% |
| MPM BioImpact LLC | 3,287,397 | $14,957,656 | 3.99% |
| Perceptive Advisors | 11,962,938 | $54,431,367 | 1.82% |
| CM Management, LLC | 200,000 | $910,000 | 0.97% |
| Velan Capital Investment Management LP | 250,000 | $1,137,500 | 0.92% |
| Opaleye Management Inc. | 610,000 | $2,775,500 | 0.90% |
| Boxer Capital, LLC | 3,705,133 | $16,858,355 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 985,000 | $4,481,750 | 0.87% |
| Parametrica Management Ltd | 95,400 | $434,070 | 0.73% |
| 683 Capital Management, LLC | 2,050,000 | $9,327,501 | 0.72% |